Acetyl-L-Carnitine (ALCAR)
SupplementLast reviewed on July 1, 2025 by SupStaq
Not medical advice. This content is general, evidence-based information and is not a substitute for professional medical advice, diagnosis, or treatment.
Medical and community ratings are largely consistent. While meta-analyses [s5, s6] show consistent but moderate effects, the community [c1, c2] reflects a similarly mixed perception — some users experience pronounced effects, others none.
Unlock full information
Dosages, side effects, studies and more, free after registration.
Register for freeRating Scales
TL;DR
ALCAR is one of the few supplements where cognitive and neuroprotective effects are supported by a credible mechanism (acetylcholine synthesis, mitochondrial fatty acid transport) and clinical data in neuropathy and fatigue are solid enough to take seriously. The safety profile is excellent — no serious adverse effects up to 3 g/day, no dependency potential. However, an estimated 30–40% of users report no noticeable effect, likely due to already-sufficient endogenous levels. Avoid evening dosing: the stimulating effect on mental energy is real enough to disrupt sleep.
Description
Acetylated form of L-carnitine that crosses the blood-brain barrier; supports mitochondrial function, acetylcholine synthesis, and cognitive performance [s1, s2, s3].
Acetyl-L-carnitine (ALCAR) is the acetylated form of L-carnitine, an endogenous compound synthesized from the amino acids lysine and methionine. Unlike standard L-carnitine, ALCAR effectively crosses the blood-brain barrier due to its additional acetyl group, exerting direct neurobiological effects therein [s2, s3]. ALCAR simultaneously delivers a carnitine and an acetyl moiety: the carnitine component supports transport of long-chain fatty acids into mitochondria for beta-oxidation, while the acetyl group contributes to the formation of acetyl-CoA, which serves as a central substrate in energy metabolism (citric acid cycle) and as a precursor for acetylcholine synthesis [s1, s4]. In clinical studies, ALCAR has been investigated primarily in mild cognitive impairment and early Alzheimer's disease [s5, s6]. A Cochrane review examined ALCAR in diabetic peripheral neuropathy [s7], and systematic reviews demonstrate improvements in sperm quality in male subfertility [s8, s9]. Additional evidence supports reduction of fatigue [s11] and antidepressant effects in elderly patients [s6]. Oral bioavailability of ALCAR preparations is higher than that of non-acetylated L-carnitine from supplements (14–18%), with peak plasma levels reached 2–4 hours after oral administration [s10]. In 2011, EFSA rejected a health claim regarding cognitive function, as the evidence was deemed insufficient [s14].
Legal Status (DE)
{'bfr_source': None, 'note': 'No retrievable BfR opinion document on maximum levels of L-carnitine/ALCAR in food supplements found within the search runs. Manual search on bfr.bund.de recommended. '}
Mechanism of Action
ALCAR acts via multiple complementary mechanisms [s1, s2, s3, s4]: 1. Acetylcholine synthesis: ALCAR crosses the blood-brain barrier and donates its acetyl group to coenzyme A, forming acetyl-CoA. This acetyl-CoA combines with choline to produce acetylcholine, the primary neurotransmitter for learning, memory, and attention [s1, s2]. 2. Mitochondrial energy metabolism: The carnitine component facilitates transport of long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. ALCAR maintains key mitochondrial proteins, enhances ATP production, and protects mitochondria against oxidative stress [s3, s4]. 3. Antioxidant protection: The carbon of the acetyl group is also utilized for glutathione (GSH) synthesis, thereby reducing oxidative damage and protecting cells from lipid peroxidation [s4]. 4. Neurotrophic modulation: ALCAR influences nerve growth factor (NGF) activity and promotes myelination and axonal growth, which is relevant in peripheral neuropathies [s7]. 5. Acetyl-CoA as a metabolic hub: The acetyl group can be oxidized, serve as an energy source, or be incorporated into glutamate, glutamine, GABA, and lipids for myelin formation [s2].
Dosing
Kognitive Funktion / Neuroprotection
- Dose
- 500–2000 mg ALCAR
- Frequency
- 1–2× täglich
- Route
- oral
- Duration
- mind. 3 Monate
- Timing
- Morning or late morning (not in the evening due to stimulating effect)
- With food
- optional
Periphere Neuropathie
- Dose
- 500–1000 mg ALCAR
- Frequency
- 2–3× täglich (Gesamtdosis 1500–3000 mg)
- Route
- oral
- Duration
- mind. 6–12 Monate
- Timing
- Evenly distributed throughout the day
- With food
- empfohlen
Männliche Subfertilität
- Dose
- 1000–2000 mg ALCAR (often combined with L-carnitine)
- Frequency
- 1–2× täglich
- Route
- oral
- Duration
- 3–6 Monate
- Timing
- Morning with or without a meal
- With food
- optional
Fatigue-Reduktion
- Dose
- 2000 mg ALCAR
- Frequency
- 2× täglich (2 g morgens + 2 g mittags)
- Route
- oral
- Duration
- 6 Monate
- Timing
- Morning and midday to avoid sleep disturbances
- With food
- empfohlen
No serious adverse effects were observed in studies at doses of 1–3 g daily [s11]. Above 3000 mg/day, body odor (fishy) may occur [s13]. No officially established maximum amount exists in Germany via BfR; the Natura Foundation cites 1–3 g as the common clinical range [s11].
Due to stimulating effects on mental energy, ALCAR should not be taken in the evening [s11]. Peak plasma levels are reached 2–4 hours after oral administration [s10].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Seizure | selten | leicht |
Contraindications
Interactions
Synergistic
ALCAR provides the acetyl group; Alpha-GPC supplies bioavailable choline – together they enhance acetylcholine synthesis in the brain. Users report improved memory performance, mental energy, and mood stability. Typical stacks use 500–1,000 mg ALCAR combined with 300–600 mg Alpha-GPC.
The combination of ALCAR and alpha-lipoic acid is considered a classic anti-aging stack for mitochondrial health. ALCAR reactivates mitochondrial enzymes, while alpha-lipoic acid reduces oxidative stress and maintains energy production. Neuroprotection and mitochondrial biogenesis have been observed in animal models.
ALCAR and citicoline together increase acetylcholine concentrations in the brain and may synergistically improve memory and cognitive performance. Citicoline supplies choline and supports cell membrane repair, while ALCAR enables acetylation. This combination is found in commercial nootropic products.
ALCAR and CoQ10 act synergistically on mitochondrial energy production and provide combined antioxidant protection in the brain and heart. An RCT meta-analysis found that the combination with L-carnitine/ALCAR improved sperm quality in infertile men. The trio ALCAR + CoQ10 + alpha-lipoic acid is regarded as a comprehensive mitochondrial supplement.
Both ALCAR and berberine activate AMPK, the central regulator of cellular energy metabolism. Combined intake could potentiate AMPK activation and synergistically improve fat and glucose metabolism. Direct combination studies in humans are currently lacking.
Community Evidence
Top reported benefits
- Improved concentration and working memory
- Increased mental energy and alertness
- Mood elevation and reduction of apathy/low drive
- Improvement of fatigue symptoms (particularly in CFS)
- Synergistic effects with other nootropics (racetams, choline)
Top reported issues
- Sleep disturbances with evening administration
- Pronounced interindividual variability – many report no effect
- Occasional irritability or inner restlessness
- Fish-smelling urine at high doses
Strong heterogeneity in user experiences: a portion of the community (estimated 30–40%) reports no perceptible effect, attributing this to already sufficient endogenous ALCAR levels [c2]. Skepticism toward placebo-effect reports [c1]. Very positive feedback in CFS forums, though often associated with sleep problems [c5, c6].
Scientific Sources
- Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
Montgomery SA, Thal LJ, Amrein R (2003). International Clinical PsychopharmacologyAPMID:12598816DOI - Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis
Veronese N, Stubbs B, Solmi M, Ajnakina O, Carvalho AF, Maggi S (2018). Psychosomatic MedicineAPMID:29076953DOI - Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update
Pennisi M, Lanza G, Cantone M, D'Amico E, Fisicaro F, Puglisi V, Vinciguerra L, Bella R, Vicari E, Malaguarnera G (2020). NutrientsBPMID:32408706DOI - ALCAR can provide an acetyl moiety that can be oxidized for energy, used as a precursor for acetylcholine, or incorporated into glutamate, glutamine and GABA, or into lipids for myelination and cell growth
Borum PR, et al. (2017). Neurochemical ResearchBPMID:28417225DOI - Carnitine – Health Professional Fact Sheet
National Institutes of Health, Office of Dietary Supplements (2022). NIH Office of Dietary SupplementsBLink - Acetyl-L-Carnitin: Vorteile, Dosierung, Kontraindikationen – Fatigue-Studie (University of Catania)
Malaguarnera M, et al. (2007). Darwin Nutrition / Natura Foundation (referenzierte Studie)BLink - BVL – Nahrungsergänzungsmittel: Anzeigepflicht und Verkehrsfähigkeit
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL) (2023). BVL.bund.deALink - Neben- und Wechselwirkungen von L-Carnitin und ALCAR
Deutsches Grünes Kreuz e.V. (2022). DGK.de – Mikronaehrstoffe LexikonBLink - Scientific Opinion on the substantiation of health claims related to acetyl-L-carnitine and contribution to normal cognitive function (ID 1432)
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011). EFSA JournalADOI - A Meta-Analysis of the Efficacy of L-Carnitine/L-Acetyl-Carnitine or N-Acetyl-Cysteine in Men With Idiopathic Asthenozoospermia
Wei G, Zhou Z, Cui Y, Huang Y, Wan Z, Che X, Chai Y, Zhang Y (2021). American Journal of Men's HealthCPMID:33906513DOI - Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis
Veronese N, Stubbs B, Solmi M, Ajnakina O, Carvalho AF, Maggi S (2018). Psychosomatic MedicineCPMID:29076953DOI - L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain
Virmani A, Binienda ZK, Bhattacharya SK, et al. (2017). Neurochemical ResearchBPMID:28417225DOI - Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression
Pettegrew JW, Levine J, McClure RJ (2000). Molecular PsychiatryBPMID:11132054DOI - Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism
Aureli T, Di Cocco ME, Calvani M, et al. (2008). NeuropharmacologyCPMID:18590920DOI - Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
Montgomery SA, Thal LJ, Amrein R (2003). International Clinical PsychopharmacologyAPMID:12598816 - Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update
Ferreira GC, McKenna MC (2020). NutrientsBPMID:32365816DOI - Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy
Rolim LCSP, da Silva EMK, Flumignan RLG, et al. (2019). Cochrane Database of Systematic ReviewsAPMID:31201734DOI - l-carnitine and l-acetylcarnitine supplementation for idiopathic male infertility
Busetto GM, Koverech A, Messano M, et al. (2020). Reproduction and FertilityADOI - Effect of L-carnitine and/or L-acetyl-carnitine in nutrition treatment for male infertility: a systematic review
Zhou X, Liu F, Zhai S (2007). Asia Pacific Journal of Clinical NutritionAPMID:17392136
Community Sources
Storage
Unopened
Store dry and cool at room temperature (15–25 °C), protected from light and moisture.
Opened
Keep packaging tightly sealed; powder form requires particular protection from moisture due to hygroscopic properties.
Notes
ALCAR is odorless and tasteless in capsule form; powder may have a slight fishy odor — this is normal and not an indicator of quality.